The Lancet RheumatologyVolume 2, Issue 8, August 2020, Pages e457-ee458CorrespondenceCanakinumab in a subgroup of patients with COVID-19Author links open overlay panelClaudio Ucciferri a d, Antonio Auricchio a, Marta Di Nicola b, Nicola Potere e, Antonio Abbate e, Francesco Cipollone c, Jacopo Vecchiet a, Katia Falasca aShow moreShareCitehttps://doi.org/10.1016/S2665-9913(20)30167-3Get rights and contentPrevious article in issueNext article in issueRecommended articlesCited by (0)View Abstract© 2020 Elsevier Ltd. All rights reserved.